WePrEP: HIV prevention tool for transgender women
Part of Infections clinical trials.
This study is creating a decision-making tool to help transgender women choose the right PrEP (HIV prevention pill) for them. It is looking for transgender women in Denver who are HIV-negative and interested in learning more about PrEP, as well as healthcare providers who help transgender women decide about PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You identify as a transgender woman (assigned male at birth, now feminine gender identity)
- You are between 18 and 65 years old
- You live in the Denver, Colorado area
- You speak English or Spanish
- You are HIV-negative
- You are not currently taking PrEP but are interested in learning more about HIV prevention
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks people who may use PrEP—an HIV prevention medicine—about their decision to start, not start, or stop PrEP. It aims to understand needs and barriers so PrEP can work better for cisgender women and transgender people who are considering it.
This study tests ways to help Black cisgender women take PrEP, a daily pill that prevents HIV infection. It focuses on making PrEP work for you.
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
This study tests whether watching short videos can help Black women learn about and start PrEP, a daily pill that prevents HIV, and also helps their healthcare providers support them. It may be a good fit if you are a Black woman interested in learning more about HIV prevention.
This study tests a program that helps Black women start PrEP (a daily pill to prevent HIV). It focuses on understanding and addressing past trauma to make it easier to take PrEP, and is designed for women who have not used PrEP before.
This study helps transgender women who are not regularly using PrEP (a daily pill to prevent HIV) get access to HIV prevention services. It uses a smartphone to take pictures and connect with support.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.